A1874 was able to degrade BRD4 (DC50 = 32 nM) and stabilize p53, thus exhibiting strong anti-proliferative effects in several p53-wild-type cancer cells, such as myeloid leukemia cells. This evidence concerns the gene BRD4 and cancer.